China Anti-hypertensive Drug Industry Indepth Research and Investment Strategic Planning Report, 2013-2017

The most distinctive characteristics of this report is forward-looking and timeliness. Through analyzing forward-looking characteristic of abundant first-hand market data, we deeply and objectively dissect China current anti-hypertensive drug industry’s overall market capacity, market size and competitive landscape. Furthermore, based on future development tracks and years' practice experience of anti-hypertensive drug industry, we conduct prudent analysis and forecast for anti-hypertensive drug industry's future development trend.

Hypertension is one of the most risk factors for cardiovascular disease. In a long term, hypertension can severely damage heart, brain, kidney as well as other organs. A range of complications, such as coronary heart disease, stroke, kidney failure, have high morbidity and mortality. According to researches abroad, hypertension is the first dangerous factor to cause death, and ranks the third for the burden of disease. With an increasing trend of aging population, the proportion of hypertension patients keeps growing. Besides, the taste of modern people is over-emphasized and they intake over salt, as well as they work busily and do little exercise, which lead to a increase of the number of hypertension patients. At present, there are 200 million hypertension patients in China, with an annual increase of 10 million patients. After many years of efforts, China's awareness rate, treatment rate and control rate are still far lower than that of developed countries. Therefore, China anti-hypertensive drug market has bright prospects for development.

The report mainly analyzes the operational conditions of China anti-hypertensive drug industry; the market environment of China anti-hypertensive drug industry; the market size and competitive landscape of anti-hypertensive drug products; the research progress of anti-hypertensive drugs; the leading corporations' operational conditions in anti-hypertensive drug industry; as well as the development trend and prospects of anti-hypertensive drug industry. Meanwhile, with comprehensive and specific first-hand market data over the past 5 years, Forward helps you to grasp the market and development trends of anti-hypertensive drug industry, so as to win advantages from competition!

The most distinctive characteristics of this report is forward-looking and timeliness. Through analyzing forward-looking characteristic of abundant first-hand market data, we deeply and objectively dissect China current anti-hypertensive drug industry’s overall market capacity, market size and competitive landscape. Furthermore, based on future development tracks and years' practice experience of anti-hypertensive drug industry, we conduct prudent analysis and forecast for anti-hypertensive drug industry's future development trend. This report helps anti-hypertensive drug manufacturing enterprises, R&D institutions, marketing enterprises and investment enterprises to precisely grasp current latest developments of the industry. Afterwards, they can make wise operating decisions and define enterprises' development directions.

Here, we would like to express our sincere gratitude to State Information Center, Bureau of Statistics of China, International Information Research Institute, Chinese Academy of International Trade and Economic Cooperation, Tsinghua University Library, Development Research Center of the State Council and Beijing Essence Forward Research Center, for their great support when we conduct this report!

Notice: All the market data, especially corporations' ranking data in the report, only for business reference. Please do not take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!

Qianzhan Business Information Co., Ltd. Industry Research Center
Research Team of Anti-hypertensive Drug Industry